Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 6585 - 6592 of 12007 results

EU Commission Confirms that Privacy Shield Survives its First Annual Review

October 18, 2017| Blog| Viewpoint

Building a Health App? Part 5: Contracting for Health App Construction

October 18, 2017| Blog| Viewpoint

Mintz Snags Ex-Foley IP Partner In San Diego

October 18, 2017| News

Hawaii Court Strikes Down Majority of President Trump’s 3rd Travel Ban

October 17, 2017| Alert| Viewpoint

US State Department “Reboots” the Diversity Visa Lottery

October 17, 2017| Alert| Viewpoint

Managing the Energy Impacts of the Massachusetts Cannabis Industry

October 17, 2017| Alert| Viewpoint

5 Daily Habits Of Rainmakers & How They Can Work For You

October 17, 2017| News

California Bans Salary History Inquiries

October 16, 2017| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases